FOAA Stock Overview
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
FONAR Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$19.80 |
52 Week High | US$21.20 |
52 Week Low | US$11.70 |
Beta | 1.12 |
1 Month Change | -5.71% |
3 Month Change | 11.24% |
1 Year Change | 41.43% |
3 Year Change | 26.11% |
5 Year Change | 6.11% |
Change since IPO | 72.99% |
Recent News & Updates
Recent updates
Shareholder Returns
FOAA | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | 1.5% | -1.2% | 1.9% |
1Y | 41.4% | 4.3% | 7.3% |
Return vs Industry: FOAA exceeded the German Medical Equipment industry which returned 4.3% over the past year.
Return vs Market: FOAA exceeded the German Market which returned 7.3% over the past year.
Price Volatility
FOAA volatility | |
---|---|
FOAA Average Weekly Movement | 5.0% |
Medical Equipment Industry Average Movement | 5.0% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.1% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: FOAA has not had significant price volatility in the past 3 months.
Volatility Over Time: FOAA's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1970 | 561 | Tim Damadian | https://www.fonar.com |
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down.
FONAR Corporation Fundamentals Summary
FOAA fundamental statistics | |
---|---|
Market cap | €129.52m |
Earnings (TTM) | €11.42m |
Revenue (TTM) | €94.65m |
11.3x
P/E Ratio1.4x
P/S RatioIs FOAA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
FOAA income statement (TTM) | |
---|---|
Revenue | US$102.42m |
Cost of Revenue | US$55.65m |
Gross Profit | US$46.77m |
Other Expenses | US$34.41m |
Earnings | US$12.36m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 1.91 |
Gross Margin | 45.67% |
Net Profit Margin | 12.07% |
Debt/Equity Ratio | 0.09% |
How did FOAA perform over the long term?
See historical performance and comparison